• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Two New Melanoma Drugs Show Boost in Survival Rate

      Melanoma, the deadliest form of skin cancer, is on the rise, with an estimated 8,700 melanoma deaths in the United States last year. Here is a good news for people suffering from melanoma. Two novel drugs ‘Vemurafenib’ and ‘Ipilimumab’ show promise for people with advanced melanoma, which may prolong their survival.

      One study presented at American Society of Clinical Oncology (ASCO) conference stated that patients treated with the drug Vemurafenib had a 63% reduced risk of death compared with those on chemotherapy. This drug specifically targets the mutated gene and helps in the shrinking of cancer cells. Within 72 hours of intake of Vemurafenib, patients found the drug to work.

      In another study, the drug Ipilimumab has been shown to increase the survival rate in late-stage melanoma patients. This drug works by stimulating the patient’s immune system, which helps to fight against the cancer.

      Both the drugs, ‘Vemurafenib’ and ‘Ipilimumab’, shrink the tumors, and thus found to increase the survival rate of melanoma patients. Doctors have further plans to explore the best use of these drugs. It is important to note that limiting exposure to strong sunlight and UV light can reduce the risk of melanoma, the most serious form of skin cancer.

      June 07, 2011


       

      Share this Article!

    Back to top^